BlackRock Fund Advisors’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$72.5M Buy
1,420,226
+231,133
+19% +$10.9M 0.01% 1431
2016
Q3
$54.8M Buy
1,189,093
+151,165
+15% +$6.15M 0.01% 1508
2016
Q2
$31.3M Buy
1,037,928
+250,382
+32% +$8.35M 0.01% 1783
2016
Q1
$25.2M Buy
787,546
+115,027
+17% +$4.05M 0.01% 1849
2015
Q4
$39.2M Sell
672,519
-65,915
-9% -$3.27M 0.01% 1647
2015
Q3
$31.3M Buy
738,434
+43,963
+6% +$2.71M 0.01% 1729
2015
Q2
$50.7M Buy
694,471
+212,931
+44% +$13.7M 0.01% 1517
2015
Q1
$24.2M Buy
481,540
+19,592
+4% +$842K 0.01% 1966
2014
Q4
$16.9M Buy
461,948
+320,341
+226% +$11.9M ﹤0.01% 2161
2014
Q3
$4.46M Buy
+141,607
New +$4.1M ﹤0.01% 2821

Other funds holding SAGE